← Leaderboards
Charles Nicholson Landen
University Of Virginia
$2,167,574
Attributed
$2,167,574
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $493.8K · FY2020–24$500K$375K$250K$125K$0
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$2,167,574 · 1
By mechanism
R01$2,167,574 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Virginia
Same institution · by research overlap
- Anja-Katrin Bielinsky$7,357,306
- Yuh-Hwa Wang$7,282,721
- Jill Slack-Davis$1,778,410
- Eric A Hendrickson$12,783,397
- Stefan Bekiranov$1,526,527
Others in their field
Other Emerging Leaders on “Drug Candidate”
- Yunda Huang · Fred Hutchinson Cancer Center$52,003,716
- Susan Abushakra · Alzheon, Inc.$47,690,244
- Thomas Rudge · Battelle Centers/Pub Hlth Res & Evaluatn$46,710,255
- Jeffrey Reich · Sparian Biosciences, Inc.$28,575,028
- Ryan Cirz · Revagenix, Inc.$22,711,751
- Alan D. Palkowitz · Indiana University Indianapolis$17,630,798
Research focus
Drug CandidateDruggable TargetDna DamageAffectDoseBiogenesisCancer SubtypesBiological ProductsCarboplatinCell LineCancer CellCessation Of LifeCancer Cell LineChemotherapyChromatin StructureClinical TrialsClustered Regularly Interspaced Short Palindromic RepeatsCombatCombinatorialCrispr LibraryCytotoxic AgentDependenceCellsEpithelial Ovarian Cancer
Grant awards (5)
Targeting RNA Polymerase I Transcription Machinery in Chemoresistant Ovarian Cancer$478,672
R01 · FY2024 · CA · contact PI
Targeting RNA Polymerase I Transcription Machinery in Chemoresistant Ovarian Cancer$493,789
R01 · FY2023 · CA · contact PI
Targeting RNA Polymerase I Transcription Machinery in Chemoresistant Ovarian Cancer$477,962
R01 · FY2022 · CA · contact PI
Targeting RNA Polymerase I Transcription Machinery in Chemoresistant Ovarian Cancer$276,135
R01 · FY2021 · CA · contact PI
Targeting RNA Polymerase I Transcription Machinery in Chemoresistant Ovarian Cancer$441,016
R01 · FY2020 · CA · contact PI